1-Benzyl-4-hydroxy-2-methyl-1H-benzo[D]imidazole-6-carboxylic acid (CAS No: 1640981-19-6) is a key pharmaceutical intermediate used in the synthesis of APIs Tegoprazan. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4-Hydroxy-2-methyl-1-(phenylmethyl)-1H-benzimidazole-6-carboxylic acid, Tegoprazan Impurity 5
CAS No: 1640981-19-6
PubChem CID: 117800723
Mol Formula: C16H14N2O3
Mol Weight: 282.29 g/mol
Used in API: Tegoprazan
IUPAC Name: 3-benzyl-7-hydroxy-2-methylbenzimidazole-5-carboxylic acid
API Intermediate Description: 1-Benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid is a heterocyclic compound featuring a benzimidazole core substituted with a benzyl group at N‑1, a hydroxyl group at C‑4, a methyl group at C‑2, and a carboxylic acid at C‑6. The combination of these functional groups provides both hydrogen-bonding capacity and lipophilic character, influencing its chemical reactivity and biological properties. This compound is commonly explored as a scaffold or intermediate in medicinal chemistry for the development of bioactive molecules.
![1-Benzyl-4-hydroxy-2-methyl-1H-benzo[D]imidazole-6-carboxylic acid](https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?cid=117800723&t=l)
